Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Recurrence and metastases after microwave ablation(MWA) of hepatocellular carcinoma(HCC) are the major factors that influence the survival. Obesity has been reported was significantly correlated with increased risk of developing HCC.
In this study, we will analysis the association of multiple obesity index(waist circumference,waist-hip ratio and body mass index) with the prognosis of HCC treated by MWA.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| survival | Percentage of participants who survived up to end time point as assessed by Kaplan-Meier | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| intra-hepatic metastasis | Percentage of participants who present metastasis in the liver up to end time point as assessed by Kaplan-Meier | 3 years |
| extra-hepatic metastasis | Percentage of participants who present metastasis outside the liver up to end time point as assessed by Kaplan-Meier |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
HCC patients are treated by ultrasound-guided percutaneous MWA
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jie Yu, Dr | Contact | 66939530 | yu-jie301@hotmail.com | |
| Meng-juan Mu, BM | Contact | 66939530 | mmj869900@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Jie Yu, Dr | Chinese PLA General Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chinese PLA General Hospital | Recruiting | Beijing | Beijing Municipality | 100853 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006528 | Carcinoma, Hepatocellular |
| D009765 | Obesity |
| ID | Term |
|---|---|
| D000230 | Adenocarcinoma |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 years |
| local tumor progression | Percentage of participants who present tumor progression around the ablation zone up to end time point as assessed by Kaplan-Meier | 3 years |
| complication | number of participants with side effect and major complication | 3 years |
| D009369 | Neoplasms |
| D008113 | Liver Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D004066 | Digestive System Diseases |
| D008107 | Liver Diseases |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |